Bluebird Bio reported $0 in Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acceleron Pharma XLRN:US $ 0M 0M
Agios Pharmaceuticals AGIO:US $ 1.01M 0.44M
Alexion Pharmaceuticals ALXN:US $ 2532M 30M
Alnylam Pharmaceuticals ALNY:US $ 433.15M 241.56M
Amgen AMGN:US $ 32782M 97M
Applied Genetic Technologies AGTC:US $ 9.98M 0.07M
Arrowhead Research ARWR:US $ 0M 0M
Avrobio Inc AVRO:US $ 0 0
Biogen BIIB:US $ 7269.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1077.11M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Immunogen IMGN:US $ 1.1M 1M
Intercept Pharmaceuticals ICPT:US $ 575.82M 7.7M
IONIS PHARMACEUT IONS:US $ 1310.54M 370.12M
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US 487M 304M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NOVN:VX SF 35769M 2030M
Ptc Therapeutics PTCT:US $ 1161.83M 15.06M
Regeneron Pharmaceuticals REGN:US $ 2697.6M 0.9M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1092.98M 1.88M
Seattle Genetics SGEN:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 524.92M 5.4M
YTE INCY:US $ 34.25M 0.22M